Plain-English translation of NCT07918001 on ClinicalTrials.gov ↗ · Source last updated · How we translate trials
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
Vietnam
Phase
Post-approval monitoring
Sponsor
IR INNOVATE RESEARCH PRIVATE LIMITED
Collaborators
Glenmark Pharmaceuticals Ltd. India
Enrollment target
~225 participants
Started
February 2026
Primary completion
February 2027
Age range
12 Years – 99 Years
Last updated on clinicaltrials.gov in November 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Dr. Nguyen Thi Phan Thuy, Doctor
Director
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.